Similarly, patients bearing tumours with high levels of angiomotin were associated with a shorter disease free survival (108.6 (92.3–125.0 95% CI) months vs 134.3 (122.0–146.7, 95%CI) months for patients with low angiomotin transcript, however, the difference was not statistically significant, p = 0.0634) (figure 5D). The gene discussed is AMOT; the disease is neoplasm.